Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for IMTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 98.45M
March 31, 2026 100.77M
December 31, 2025 91.89M
September 30, 2025 119.71M
June 30, 2025 120.59M
March 31, 2025 113.51M
December 31, 2024 125.61M
September 30, 2024 217.30M
June 30, 2024 256.23M
March 31, 2024 272.53M
December 31, 2023 314.69M
September 30, 2023 200.84M
June 30, 2023 209.45M
March 31, 2023 193.83M
Date Value
December 31, 2022
September 30, 2022
June 30, 2022 254.42M
March 31, 2022 184.92M
December 31, 2021 171.24M
September 30, 2021 189.78M
June 30, 2021 166.10M
March 31, 2021 169.34M
December 31, 2020 204.65M
September 30, 2020 189.24M
June 30, 2020 197.59M
March 31, 2020 188.51M
December 31, 2019 196.56M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
MediGene AG --
InflaRx NV 23.69M
BioNTech SE 2.956B
Moderna, Inc. 4.20B
Intellia Therapeutics, Inc. 129.46M

Total Liabilities (Quarterly) Related Metrics